Form SC 13G - Statement of Beneficial Ownership by Certain Investors

S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Alto Neuroscience (NYSE:ANRO)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Alto Neuroscience Charts.

Alto Neuroscience (NYSE:ANRO)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Alto Neuroscience Charts.

Alto Neuroscience Inc News

Alto Neuroscience Announces Data Presented at the 63rd Annual Meeting of the American College of Neuropsychopharmacology
Thursday 12 December 2024 (2 weeks ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 13 November 2024 (1 month ago) • Edgar (US Regulatory)

Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Wednesday 13 November 2024 (1 month ago) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Saturday 9 November 2024 (1 month ago) • Edgar (US Regulatory)

Alto Neuroscience to Participate in Upcoming Investor Conferences
Tuesday 5 November 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Wednesday 23 October 2024 (2 months ago) • Edgar (US Regulatory)

Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder
Wednesday 23 October 2024 (2 months ago) • Business Wire

Alto Neuroscience Announces Peer-Reviewed Publication in the Journal of Clinical Psychiatry Demonstrating Baseline Cognitive Performance is Not a Moderator of Response to Standard-of-Care Antidepressants
Wednesday 4 September 2024 (4 months ago) • Business Wire

Alto Neuroscience to Participate in Upcoming Investor Conferences
Tuesday 3 September 2024 (4 months ago) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 14 August 2024 (4 months ago) • Edgar (US Regulatory)

More Alto Neuroscience Inc News Articles

Xtrackers Japan Net Zero...

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions